background
molecular
assay
gold
standard
method
use
diagnos
viral
respiratori
pathogen
pitfal
associ
techniqu
includ
limit
number
target
pathogen
requir
continu
monitor
ensur
sensitivityspecif
maintain
need
evolv
includ
emerg
pathogen
introduc
target
independ
next
gener
sequenc
ng
could
resolv
issu
revolutionis
respiratori
viral
diagnost
object
compar
sensit
specif
target
independ
ng
current
standard
diagnost
test
studi
design
diagnost
rtpcr
clinic
sampl
carri
parallel
target
independ
ng
ng
sequenc
analyz
determin
proport
viral
origin
consensu
sequenc
use
establish
viral
genotyp
serotyp
applic
result
nasopharyng
swab
test
viral
pathogen
detect
sampl
ng
rtpcr
ng
viral
detect
confirm
rtpcr
conclus
target
independ
ng
detect
viral
pathogen
clinic
sampl
virus
detect
rtpcr
alon
ct
valu
higher
detect
assay
suggest
ng
detect
cutoff
ct
sensit
specif
ng
compar
rtpcr
respect
lower
current
diagnost
assay
ng
provid
full
genom
sequenc
case
allow
determin
viral
subtyp
serotyp
sequenc
technolog
improv
rapidli
like
within
short
period
time
sequenc
depth
increas
inturn
improv
test
sensit
viru
specif
molecular
assay
realtim
pcr
rtpcr
consid
gold
standard
diagnosi
viral
respiratori
tract
infect
rapid
rel
inexpens
offer
increas
sensit
specif
prior
techniqu
abbrevi
rtpcr
realtim
polymeras
chain
reaction
ng
next
gener
sequenc
np
nasopharyng
swab
vtm
viral
transport
medium
hrv
human
rhinoviru
ifa
influenza
ifb
influenza
b
rsv
respiratori
syncyti
viru
adv
adenoviru
hmpv
human
metapneumoviru
parainfluenza
viru
hcov
human
coronaviru
wossvc
west
scotland
specialist
virolog
center
hev
human
enteroviru
ct
cycl
threshold
blast
basic
local
align
search
tool
trt
turnaround
time
correspond
author
email
address
fiona
thorburn
hotmailcom
f
thorburn
viru
cultur
direct
immunofluoresc
assay
develop
quickli
detect
novelemerg
pathogen
combin
identifi
multipl
microbiolog
pathogen
singl
test
yet
limit
number
target
usual
four
includ
inhous
test
compromis
test
sensit
result
diagnost
laboratori
must
develop
panel
multiplex
test
order
detect
whole
rang
pathogen
also
pcr
base
assay
detect
base
target
conserv
region
pathogen
genom
mutat
lead
reduc
sensit
fals
neg
result
furthermor
target
pathogen
includ
assay
identifi
therefor
atyp
emerg
pathogen
gener
evad
detect
pcr
although
commerci
pcr
base
test
avail
overcom
pitfal
associ
inhous
test
remain
pcr
base
technolog
result
suffer
sequenc
base
pitfal
outlin
introduc
ng
diagnost
set
may
revolution
investig
respiratori
infect
combin
sequenc
independ
amplif
ng
potenti
detect
viral
nonvir
pathogen
within
clinic
specimen
without
activ
target
simultan
analyz
genet
sequenc
ng
establish
viru
discoveri
whole
genom
studi
metagenom
studi
thu
simultan
detect
multipl
differ
pathogen
techniqu
possibl
howev
efficaci
feasibl
employ
techniqu
diagnost
set
requir
studi
present
pilot
studi
compar
current
diagnost
techniqu
name
rtpcr
ng
detect
rna
virus
respiratori
sampl
individu
symptomat
respiratori
ill
eighti
nine
nasopharyng
swab
np
collect
adult
upper
respiratori
tract
infect
may
octob
sampl
collect
part
vidari
trial
random
subset
use
studi
note
half
particip
trial
vaccin
influenza
ethic
approv
provid
upper
south
b
region
ethic
committe
particip
provid
written
inform
consent
swab
store
viral
transport
media
vtm
c
test
vtm
thaw
c
centrifug
g
min
remov
debri
total
nucleic
acid
extract
l
supernat
magjet
viral
dna
rna
kit
thermo
scientif
elut
l
water
l
aliquot
extract
treat
dnase
turbo
dnase
life
technolog
min
c
rna
purifi
reaction
use
rnaclean
xp
bead
agencourt
elut
l
water
revers
transcript
carri
use
maxima
minu
h
thermofish
c
min
primer
gcc
gga
gct
ctg
cag
ata
tcn
nnn
nn
second
strand
cdna
synthesis
nebnext
mrna
strand
synthesi
new
england
biolab
reaction
purifi
ampur
xp
bead
agencourt
sequenceindepend
singl
primer
amplif
sispa
carri
advantag
pcr
kit
clontech
primer
gcc
gga
gct
ctg
cag
ata
tc
pcr
product
purifi
ampur
xp
bead
agencourt
quantifi
qubit
hs
dna
life
technolog
ng
cdna
use
prepar
barcod
sequenc
librari
nextera
xt
dna
sampl
prep
kit
illumina
indic
nextera
xt
index
kit
per
manufactur
instruct
sampl
librari
pool
per
sequenc
run
bp
pairedend
read
gener
illumina
miseq
sequenc
adapt
low
qualiti
sequenc
read
remov
trim
galor
babraham
bioinformat
lowcomplex
read
filter
prinseq
high
qualiti
pairedend
sequenc
retain
downstream
analys
sequenc
map
databas
contain
human
genom
cdna
refer
remov
host
sequenc
unmap
sequenc
enter
metamo
pipelin
employ
multipl
de
novo
assembl
kmer
optimis
assembl
contig
contig
effect
assembl
taxonom
classifi
use
basic
local
align
search
tool
blast
genbank
nucleotid
nonredund
databas
cut
e
valu
ident
sequenc
sampl
remov
use
bedtool
uniqu
sequenc
retain
analysi
sequenc
read
map
back
top
taxonom
hit
sampl
visual
use
tablet
quantifi
viral
read
within
sampl
gener
consensu
sequenc
appropri
greater
refer
genom
coverag
consensu
sequenc
align
known
refer
sequenc
phylogenet
analysi
carri
use
taxonom
hit
compar
result
diagnost
qrtpcr
tabl
l
nucleic
acid
extract
screen
human
rhinoviru
hrv
influenza
ab
ifaifb
respiratori
syncyti
viru
rsv
adenoviru
adv
human
metapneumoviru
hmpv
parainfluenzaviru
piv
coronavirus
hcov
mycoplasma
pneumonia
use
routin
diagnost
qrtpcr
west
scotland
specialist
virolog
centr
wossvc
previous
describ
averag
number
sequenc
gener
per
sampl
rang
qualiti
trim
filter
viral
contig
found
sampl
follow
remov
duplic
read
reduc
subset
sampl
n
fewer
uniqu
viral
read
detect
ng
assay
alon
due
low
number
read
deem
neg
ng
viral
sequenc
detect
remain
sampl
belong
picornavirida
coronavirida
paramyxovirida
orthomyxovirida
tabl
mix
infect
detect
ng
picornavirus
frequent
detect
n
classifi
hrv
enteroviru
hev
case
could
subdivid
rhinoviru
speci
b
c
hev
picornaviru
sequenc
gener
ng
show
high
similar
nucleotid
level
refer
genom
avail
ncbi
databas
allow
us
assign
serotyp
one
case
tabl
extent
refer
genom
coverag
phylogenet
similar
refer
sequenc
shown
fig
respect
numer
hrv
serotyp
detect
human
coronavirus
hcov
detect
nine
sampl
found
belong
follow
type
hcov
hcov
hcov
paramyxovirus
detect
seven
sampl
includ
hmpvb
rsva
rsvb
orthomyxoviru
detect
one
sampl
type
influenza
virus
identifi
ng
confirm
qrtpcr
howev
eleven
case
viru
identifi
rtpcr
includ
follow
virus
adv
hmpv
rsv
hcov
hrv
one
sampl
found
rtpcr
contain
mixtur
adv
hrv
ng
method
fail
detect
adv
sampl
ng
confirm
find
rtpcr
assay
ct
valu
sig
examin
relationship
number
viral
sequenc
read
threshold
cycl
ct
valu
provid
rtpcr
assay
shown
fig
log
percentag
sequenc
read
correl
ct
valu
indic
higher
viral
load
associ
greater
proport
viral
read
despit
sampl
treatment
enrich
viral
rna
substanti
number
bacteri
transcript
sequenc
gener
howev
partial
genom
amplif
bacteria
allow
classif
level
orderfamili
data
shown
pilot
studi
design
assess
util
ng
method
detect
respiratori
rna
virus
compar
inhous
ng
method
establish
inhous
rtpcr
test
use
respiratori
sampl
viral
pathogen
detect
ng
method
sampl
rtpcr
confirm
detect
virus
overal
base
result
ng
assay
sensit
ci
specif
ci
ci
consid
sampl
fewer
uniqu
read
neg
compar
rtpcr
possibl
sensit
ng
detect
could
vari
viru
group
howev
number
detect
cohort
power
assess
individu
ng
negativertpcr
posit
sampl
contain
viru
lower
ct
compar
posit
assay
suggest
current
ng
method
cut
region
ct
approxim
log
less
sensit
qrtpcr
method
data
shown
find
similar
outlin
prachayangprecha
et
al
present
level
sensit
appropri
diagnost
servic
replac
qrtpcr
increas
depth
sequenc
could
improv
sensit
ng
either
reduc
multiplex
sampl
ie
reduc
number
sampl
process
per
sequenc
run
use
altern
platform
greater
capac
illumina
nextseq
hiseq
reduc
contamin
host
dna
host
dna
deplet
hold
greatest
promis
increas
depth
viral
microbi
dna
found
read
obtain
per
sampl
deriv
host
one
pathogen
detect
ng
method
adenoviru
unclear
whether
due
sensit
cut
discuss
ct
due
initi
dnase
step
outlin
method
futur
adapt
detect
dna
virus
non
viral
caus
respiratori
infect
way
enrich
need
sought
perhap
target
enrich
via
hybrid
may
encount
issu
miss
novel
chang
virus
although
ng
method
fail
detect
posit
sampl
offer
sever
advantag
rtpcr
method
exampl
ng
provid
detail
type
inform
detect
virus
includ
subtyp
data
rsv
hmpv
well
serotyp
data
hrv
hev
inform
highli
inform
well
enabl
realtim
diagnost
data
produc
ng
could
simultan
provid
resist
test
eg
mutat
influenza
confer
oseltamivir
resist
type
data
demonstr
previous
could
use
inform
public
health
circul
strain
could
allow
rapid
detect
emerg
novel
subtyp
eg
adv
highlight
potenti
outbreak
futur
may
also
detect
viral
polymorph
associ
diseas
sever
similar
studi
also
found
correl
ng
sequenc
read
rtpcr
cycl
threshold
particularli
strong
rhinovirus
mainli
repres
major
pathogen
detect
suggest
sequenc
read
might
suitabl
proxi
viraltarget
copi
would
enabl
laboratoriesclinician
interpret
clinic
relev
result
data
also
use
infer
prognosi
treatment
respons
viral
coinfect
detect
ng
could
assess
cohort
singl
coinfect
episod
detect
rtpcr
popul
studi
normal
healthi
adult
requir
health
care
intervent
littl
inform
coinfect
individu
evid
suggest
viral
coinfect
occur
commonli
hospitalis
individu
detect
influenza
also
lower
may
expect
probabl
relat
level
vaccin
amongst
cohort
studi
includ
children
unvaccin
individu
would
use
ng
approach
detect
posit
result
miss
rtpcr
although
panel
small
data
support
studi
conclud
current
respiratori
panel
appropri
detect
main
caus
viral
respiratori
diseas
major
barrier
introduct
ng
routin
diagnost
test
cost
turnaround
time
current
cost
sequenc
prohibit
diagnost
test
compar
rtpcr
reduc
recent
year
trend
probabl
continu
futur
although
design
detect
bacteria
current
method
still
detect
bacteri
genom
nearli
sampl
find
show
syndrom
test
possibl
viral
bacteri
fungal
diagnost
test
combin
singl
assay
would
benefit
cost
effect
develop
ng
diagnost
tool
turnaroundtim
process
region
seven
day
includ
preliminari
data
analysi
wherea
turnaround
time
rtpcr
method
usual
hour
result
ng
unlik
becom
routin
diagnost
test
near
term
howev
mani
step
could
acceler
autom
develop
kit
base
librari
prepar
method
also
result
condens
process
reduc
handson
time
technic
advanc
allow
greater
depth
sequenc
could
obviat
need
enrich
process
furthermor
third
gener
sequenc
pacbio
rs
ii
offer
potenti
even
rapid
sequenc
taken
togeth
advanc
like
improv
trt
ng
significantli
none
declar
studi
fund
uk
medic
research
council
grant
refer
number
studi
approv
upper
south
b
region
ethic
committe
new
zealand
particip
provid
written
inform
consent
